Cleared Traditional

K220434 - Blue Eye (TS-905) (FDA 510(k) Clearance)

Aug 2022
Decision
178d
Days
Class 2
Risk

K220434 is an FDA 510(k) clearance for the Blue Eye (TS-905). This device is classified as a Submucosal Injection Agent (Class II - Special Controls, product code PLL).

Submitted by The Standard Co., Ltd. (Gunpo-Si, KR). The FDA issued a Cleared decision on August 12, 2022, 178 days after receiving the submission on February 15, 2022.

This device falls under the Gastroenterology & Urology FDA review panel. Regulated under 21 CFR 876.1500. Intended For Use In Gastrointestinal Endoscopic Procedures For Submucosal Lift Of Polyps, Adenomas, Early-stage Cancers Or Other Gastrointestinal Mucosal Lesions, Prior To Excision With A Snare Or Endoscopic Device..

Submission Details

510(k) Number K220434 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 15, 2022
Decision Date August 12, 2022
Days to Decision 178 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary Summary PDF

Device Classification

Product Code PLL - Submucosal Injection Agent
Device Class Class II - Special Controls
CFR Regulation 21 CFR 876.1500
Definition Intended For Use In Gastrointestinal Endoscopic Procedures For Submucosal Lift Of Polyps, Adenomas, Early-stage Cancers Or Other Gastrointestinal Mucosal Lesions, Prior To Excision With A Snare Or Endoscopic Device.